Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Subhasree Kar

What Should Pharma Investors Plan to Do With Canopy Growth (CGC) this Month?

Despite a strong start following the legalization of pot in Canada, Canadian pot producer Canopy Growth Corporation (CGC) is doubtful about its ability to stay afloat as its loss-making streak continued in the first quarter.

While the company has taken several initiatives to strengthen its financial position through further reducing cash burn, monetizing non-core assets, reducing debt, and turning profitable, the success of these initiatives remains to be seen.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.